HEALIOS K.K. announced the appointment of new executive officers and its new management team. Richard P. Kincaid as Executive Officer & CFO. Richard P. Kincaid has been a financial industry professional in Japan and Asia for the past 19 years.

He has served as a director of Healios since March 2018. David W. Smith as Executive Officer in charge of manufacturing. David W. Smith began his career as a pharmacist, and then experienced various roles in the pharmaceutical industry.

Since 2002 he led a cell therapy contract manufacturing business, then served as the Vice President, Global Business Development for Lonza Corporation, one of the larger cell therapy manufacturing service organizations in the industry. He has served as a director of Healios since March 2018, and then assumed the role of Chief Commercial Officer of Healios NA Inc. in August 2018. Koji Abe as Executive Officer in charge of human resources and general affairs.

Koji Abe has 30 years of experience in the human resource field at technology R&D companies. In 2005 he joined Sysmex Corporation and revised the personnel framework and established a new talent development program as Vice President, and then Executive Vice President of HR. He joined Healios in April 2019.

Mr. Sawada newly assumes the position of Executive Vice President. Mr. Smith concurrently serves as Chief Commercial Officer of Healios NA Inc., United States based subsidiary company.